Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Rhythm Biosciences Ltd. ( (AU:RHY) ).
Rhythm Biosciences has applied to the ASX for quotation of 18,834,007 new ordinary fully paid shares under its RHY ticker. The newly issued securities, which form part of previously announced transactions, were dated 15 April 2026 and will expand the company’s quoted share capital, potentially increasing liquidity and broadening its investor base.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian biotechnology company listed on the ASX that operates in the life sciences sector. The company focuses on developing and commercialising diagnostic technologies, with its ordinary fully paid shares traded under the ticker RHY, giving investors equity exposure to its biosciences initiatives.
Average Trading Volume: 976,474
Technical Sentiment Signal: Buy
Current Market Cap: A$63.87M
For a thorough assessment of RHY stock, go to TipRanks’ Stock Analysis page.